Publicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (21)

2022

  1. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Expression of the cold thermoreceptor TRPM8 in rodent brain thermoregulatory circuits

    Journal of Comparative Neurology, Vol. 529, Núm. 1, pp. 234-256

  2. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

  3. SUMOylation modulates the stability and function of PI3K-p110β

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 8, pp. 4053-4065

2020

  1. Molecular profiling for acromegaly treatment: a validation study

    Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389

2017

  1. The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways

    Scientific Reports, Vol. 7

2015

  1. SUMOylation regulates AKT1 activity

    Oncogene, Vol. 34, Núm. 11, pp. 1442-1450

2014

  1. The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole

    Neurodegenerative Diseases, Vol. 13, Núm. 2-3, pp. 171-179

2012

  1. History and therapeutic use of MAO-A inhibitors: A historical perspective of MAO-A inhibitors as antidepressant drug

    Current Topics in Medicinal Chemistry, Vol. 12, Núm. 20, pp. 2275-2282

2008

  1. Pendred syndrome in two Galician families: Insights into clinical phenotypes through cellular, genetic, and molecular studies

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 1, pp. 267-277

1995

  1. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats

    Neuroendocrinology, Vol. 61, Núm. 5, pp. 552-558

  2. Regulation of hypothalamic somatostatin by glucocorticoids

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 53, Núm. 1-6, pp. 277-282

1993

  1. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin

    Neuroendocrinology, Vol. 57, Núm. 6, pp. 1155-1160

  2. Glucocorticoids may inhibit growth hormone release by enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 439-444

  3. Studies on α2-adrenergic modulation of hypothalamic somatostatin secretion in rats

    Life Sciences, Vol. 53, Núm. 8, pp. 665-668

1992

  1. Neuroendocrine control of growth hormone secretion in humans

    Trends in Endocrinology and Metabolism

1991

  1. Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man

    Clinical Endocrinology, Vol. 35, Núm. 2, pp. 129-135

  2. Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 73, Núm. 2, pp. 251-256

  3. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 40, Núm. 1-3, pp. 165-173

1990

  1. α2-adrenergic agonism enhances the growth hormone (gh) response to gh-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men

    Journal of Clinical Endocrinology and Metabolism, Vol. 71, Núm. 6, pp. 1581-1588